首頁 > 市場調查報告書 > 醫療設備

眼科設備

市場調查報告書

商品編碼

1542919

全球雷射間接檢眼鏡市場 - 2024-2031

Global Laser Indirect Ophthalmoscope Market - 2024-2031

出版日期: 2024年08月26日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

報告概述

2023年，全球雷射間接檢眼鏡市場達到1.1529億美元，預計2031年將達到1.6049億美元，2024-2031年預測期間複合年成長率為4.3%。

雷射間接檢眼鏡會產生令人眼花撩亂的曝光和短暫的殘像，但沒有證據表明它們在常規臨床使用中會導致光化學或熱視網膜損傷。集中在單一視網膜區域的 15 分鐘曝光可能會對麻醉的恒河猴造成局部光毒性損傷。儘管如此，在失明或需要摘除眼睛的人類志願者中，仍無法檢測到立即或長期的視網膜異常。

市場動態：

驅動程式和限制

雷射間接檢眼鏡進步的興起

雷射間接檢眼鏡的技術進步，例如影像品質的提升、便攜性和易用性，也促進了市場的成長。這些進步使這些設備對醫療保健提供者來說更容易使用和更具吸引力。數位成像和擴增實境等技術正在增強雷射間接檢眼鏡的功能，從而可以更好地可視化和診斷眼睛狀況。

例如，Norlase 推出了 LION，這是一種新型雷射間接檢眼鏡 (LIO)，它結合了綠色雷射光凝器和 Keeler 間接檢眼鏡。這款電池供電的 LIO 不需要光纖繫繩，並使用先進的無線介面和語音控制參數。這使得眼科醫生幾乎可以在任何地方體驗不受束縛、輕盈、攜帶式的雷射治療解決方案。

監管挑戰

雷射間接檢眼鏡在市場上面臨許多監管挑戰。其中包括獲得 FDA 對新型號的許可、滿足監管機構制定的安全和性能標準、遵守標籤和文件要求、適應各國不同的監管框架，以及隨著更先進的型號的推出而管理日益嚴格的監管審查。這些挑戰增加了開發過程的時間和成本，並使雷射間接檢眼鏡製造商的全球商業化工作變得複雜。

Laser Indirect Ophthalmoscopes produce dazzling exposures and transient afterimages, but there is no evidence that they cause photochemical or thermal retinal injury in routine clinical use. A 15-minute exposure focused on a single retinal area can cause localized phototoxic injury in an anesthetized rhesus monkey. Still, no immediate or long-term retinal abnormalities could be detected in human volunteers with blind eyes or those requiring enucleation.

Market Dynamics: Drivers & Restraints

Rise of advancements in laser indirect ophthalmoscope

Technological advancements in laser indirect ophthalmoscopes, such as improved image quality, portability, and ease of use, are also contributing to the market's growth. These advancements make the devices more accessible and attractive to healthcare providers. Technologies like digital imaging and augmented reality are enhancing the capabilities of laser indirect ophthalmoscopes, allowing for better visualization and diagnosis of eye conditions.

For instance, Norlase has introduced the LION, a new laser indirect ophthalmoscope (LIO) that combines a green laser photocoagulator with a Keeler indirect ophthalmoscope. This battery-powered LIO requires no fiber tether and uses an advanced wireless interface with voice control of parameters. This allows ophthalmologists to experience an untethered, lightweight, and portable laser treatment solution virtually anywhere.

Regulatory challenges

The laser indirect ophthalmoscope faces numerous regulatory challenges in the market. These include obtaining FDA clearance for new models, meeting safety and performance standards set by regulatory bodies, adhering to labeling and documentation requirements, navigating differing regulatory frameworks across countries, and managing increased regulatory scrutiny as more advanced models are introduced. These challenges add time and costs to the development process and complicate global commercialization efforts for laser indirect ophthalmoscope makers.

Segment Analysis

The global laser indirect ophthalmoscope market is segmented based on laser type, therapeutic application, end-user, and region.

The photocoagulation laser from the laser type segment accounted for approximately 42.3% of the laser indirect ophthalmoscope market share

The photocoagulating laser from the laser type segment accounted for approximately 42.3%. Photocoagulation lasers, like argon and diode lasers, are widely used to treat retinal conditions like diabetic retinopathy and retinal vein occlusion by sealing blood vessels and reducing vision loss risk. This segment is expected to dominate due to increasing retinal disease incidence and photocoagulation therapy effectiveness.

For instance, in May 2023, Norlase, a leading global ophthalmic laser manufacturer developing next-generation laser solutions, announced it had received both FDA 510(k) clearance and CE Mark approval for the ECHO Green Pattern Laser photocoagulator.

Geographical Analysis

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors like novel product launches, investment by key players, advanced healthcare infrastructure, high adoption of advanced medical technologies, and increasing healthcare expenditure. However, rapid economic development, growing healthcare investments,

For instance, in May 2023, Norlase, a leading laser technology company, secured its largest investment round to date, raising $11 million. The funding will enable Norlase to accelerate the production of its ECHO pattern laser, which has received FDA clearance and CE Mark. The investment will also advance Norlase's laser treatment solution portfolio. West Hill Capital led the round.

Competitive Landscape

The major global players in the market include Iridex Corporation, Meridian AG, Lumenis, Ellex Medical Lasers, Carl Zeiss Meditec AG, Nidek Co. Ltd., Ziemer Ophthalmic Systems AG, Heine Optotechnik GmbH, Keeler Ltd, Topcon Medical Laser Systems Inc among others.

Key Developments

In January 2021, Norlase announced that it had been granted the European CE Mark for the LION green laser system. LION combines the Keeler Vantage Plus diagnostic indirect with Norlase's groundbreaking compact laser technology into one device. With LION's untethered and portable design, physicians can move freely between treatment rooms - conveniently treating patients anywhere, anytime.

Why Purchase the Report?

To visualize the global laser indirect ophthalmoscope market segmentation based on laser type, therapeutic application, end user, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

excel data sheet with numerous data points of the laser indirect ophthalmoscope market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as Excel consisting of key products of all the major players.

The global laser indirect ophthalmoscope market report would provide approximately 64 tables, 61 figures, and 186 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Laser Type
3.2. Snippet by Therapeutic Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise of advancements in laser indirect ophthalmoscope
  - 4.1.1.2. Rise in the prevalence of eye disorders
- 4.1.2. Restraints
  - 4.1.2.1. Regulatory challenges
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. PESTLE Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Laser Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Laser Type
- 6.1.2. Market Attractiveness Index, By Laser Type
6.2. Photocoagulation laser *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Photo disrupting laser
6.4. Photo ablating laser

7. By Therapeutic Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Application
- 7.1.2. Market Attractiveness Index, By Therapeutic Application
7.2. Diabetic retinopathy*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Cataract
7.4. Corneal opacities
7.5. Glaucoma
7.6. Pediatric retinal repairs
7.7. Lattice degeneration

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ophthalmic Clinics
8.4. Ambulatory Surgery Centers (ASCs)
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Laser Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Laser Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Laser Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Laser Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Laser Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Iridex Corporation*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Meridian AG
11.3. Lumenis
11.4. Ellex Medical Lasers
11.5. Carl Zeiss Meditec AG
11.6. Nidek Co. Ltd.
11.7. Ziemer Ophthalmic Systems AG
11.8. Heine Optotechnik GmbH
11.9. Keeler Ltd
11.10. Topcon Medical Laser Systems Inc (*LIST NOT EXHAUSTIVE)